Clinical Trial Update: Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated how IL-28B rs12979860 genotype influences virological response in chronic Hepatitis C treatment; the study has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Sheikh Zayed Medical College | Conditions: Hepatitis C, Hepatitis C Relapse | Phase 3 | Status: COMPLETED